|
1
|
Gruber M, Darr R and Eisenhofer G:
Pheochromocytoma: Update on diagnosis and therapy. Dtsch Med
Wochenschr. 139:486–490. 2014.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reisch N, Peczkowska M, Januszewicz A and
Neumann HP: Pheochromocytoma: Presentation, diagnosis and
treatment. J Hypertens. 24:2331–2339. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nölting S, Grossman A and Pacak K:
Metastatic phaeochromocytoma: Spinning towards more promising
treatment options. Exp Clin Endocrinol Diabetes. 127:117–128. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Soltani A, Pourian M and Davani BM: does
this patient have pheochromocytoma? a systematic review of clinical
signs and symptoms. J Diabetes Metab Disord. 15:62015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hori T, Yamagiwa K, Hayashi T, Yagi S,
Iida T, Taniguchi K, Kawarada Y and Uemoto S: Malignant
pheochromocytoma: Hepatectomy for liver metastases. World J
Gastrointest Surg. 5:309–313. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ayala-Ramirez M, Feng L, Johnson MM, Ejaz
S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, et al:
Clinical risk factors for malignancy and overall survival in
patients with pheochromocytomas and sympathetic paragangliomas:
Primary tumor size and primary tumor location as prognostic
indicators. J Clin Endocrinol Metab. 96:717–725. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei S, Wu D and Yue J: Surgical resection
of multiple liver metastasis of functional malignant
pheochromocytoma: A case report and literature review. J Cancer Res
Ther. 9 (Suppl):S183–S185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morikawa T, Suzuki M, Unno M, Endo K,
Katayose Y and Matsuno S: Malignant pheochromocytoma with hepatic
metastasis diagnosed 10 years after a resection of the primary
incidentaloma adrenal lesion: Report of a case. Surgery Today.
31:80–84. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hidaka S, Hiraoka A, Ochi H, Uehara T,
Ninomiya T, Miyamoto Y, Hasebe A, Tanihira T, Tanabe A, Ichiryu M,
et al: Malignant pheochromocytoma with liver metastasis treated by
transcatheter arterial chemo-embolization (TACE). Intern Med.
49:645–651. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tanaka S, Ito T, Tomoda J, Higashi T,
Yamada G and Tsuji T: Malignant pheochromocytoma with hepatic
metastasis diagnosed 20 years after resection of the primary
adrenal lesion. Intern Med. 32:789–794. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nicoś M, Jarosz B, Krawczyk P,
Wojas-Krawczyk K, Kucharczyk T, Sawicki M, Pankowski J, Trojanowski
T and Milanowski J: Screening for ALK abnormalities in central
nervous system metastases of non-small-cell lung cancer. Brain
Pathol. 28:77–86. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Keiser HR, Goldstein DS, Wade JL, Douglas
FL and Averbuch SD: Treatment of malignant pheochromocytoma with
combination chemotherapy. Hypertension. 7:118–124. 1985. View Article : Google Scholar
|
|
13
|
Lenders JW, Duh QY, Eisenhofer G,
Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K and
Young WF Jr; Endocrine Society, : Pheochromocytoma and
paraganglioma: An endocrine society clinical practice guideline. J
Clin Endocrinol Metab. 99:1915–1942. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Motta-Ramirez GA, Remer EM, Herts BR, Gill
IS and Hamrahian AH: Comparison of CT findings in symptomatic and
incidentally discovered pheochromocytomas. AJR Am J Roentgenol.
185:684–688. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Canu L, Van Hemert JAW, Kerstens MN,
Hartman RP, Khanna A, Kraljevic I, Kastelan D, Badiu C, Ambroziak
U, Tabarin A, et al: CT Characteristics of Pheochromocytoma:
Relevance for the Evaluation of Adrenal Incidentaloma. J Clin
Endocrinol Metab. 104:312–318. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Blake MA, Krishnamoorthy SK, Boland GW,
Sweeney AT, Pitman MB, Harisinghani M, Mueller PR and Hahn PF:
Low-density pheochromocytoma on CT: A mimicker of adrenal adenoma.
AJR Am J Roentgenol. 181:1663–1668. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Adam SZ, Nikolaidis P, Horowitz JM,
Gabriel H, Hammond NA, Patel T, Yaghmai V and Miller FH: Chemical
shift MR imaging of the adrenal gland: Principles, pitfalls, and
applications. Radiographics. 36:414–432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahmed AA, Thomas AJ, Ganeshan DM, Blair
KJ, Lall C, Lee JT, Morshid AI, Habra MA and Elsayes KM: Adrenal
cortical carcinoma: Pathology, genomics, prognosis, imaging
features, and mimics with impact on management. Abdom Radiol (NY).
45:945–963. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Herr K, Muglia VF, Koff WJ and Westphalen
AC: Imaging of the adrenal gland lesions. Radiol Bras. 47:228–239.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tanabe A, Naruse M, Nomura K, Tsuiki M,
Tsumagari A and Ichihara A: Combination chemotherapy with
cyclophosphamide, vincristine, and dacarbazine in patients with
malignant pheochromocytoma and paraganglioma. Horm Cancer.
4:103–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
